Logo of biochemjBJ Latest papers and much more!
Biochem J. Jul 1, 1998; 333(Pt 1): 183–191.
PMCID: PMC1219571

A structural comparison of the colicin immunity proteins Im7 and Im9 gives new insights into the molecular determinants of immunity-protein specificity.


We report the first detailed comparison of two immunity proteins which, in conjunction with recent protein engineering data, begins to explain how these structurally similar proteins are able to bind and inhibit the endonuclease domain of colicin E9 (E9 DNase) with affinities that differ by 12 orders of magnitude. In the present work, we have determined the X-ray structure of the Escherichia coli colicin E7 immunity protein Im7 to 2.0 A resolution by molecular replacement, using as a trial model the recently determined NMR solution structure of Im9. Whereas the two proteins adopt similar four-helix structures, subtle structural differences, in particular involving a conserved tyrosine residue critical for E9 DNase binding, and the identity of key residues in the specificity helix, lie at the heart of their markedly different ability to bind the E9 DNase. Two other crystal structures were reported recently for Im7; in one, Im7 was a monomer and was very similar to the structure reported here, whereas in the other it was a dimer to which functional significance was assigned. Since this previous work suggested that Im7 could exist either as a monomer or a dimer, we used analytical ultracentrifugation to investigate this question further. Under a variety of solution conditions, we found that Im7 only ever exists in solution as a monomer, even up to protein concentrations of 15 mg/ml, casting doubt on the functional significance of the crystallographically observed dimer. This work provides a structural framework with which we can understand immunity-protein specificity, and in addition we believe it to be the first successfully refined crystal structure solved by molecular replacement using an NMR trial model with less than 100% sequence identity.

Full Text

The Full Text of this article is available as a PDF (576K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • James R, Kleanthous C, Moore GR. The biology of E colicins: paradigms and paradoxes. Microbiology. 1996 Jul;142(Pt 7):1569–1580. [PubMed]
  • Ohno-Iwashita Y, Imahori K. Assignment of the functional loci in colicin E2 and E3 molecules by the characterization of their proteolytic fragments. Biochemistry. 1980 Feb 19;19(4):652–659. [PubMed]
  • Di Masi DR, White JC, Schnaitman CA, Bradbeer C. Transport of vitamin B12 in Escherichia coli: common receptor sites for vitamin B12 and the E colicins on the outer membrane of the cell envelope. J Bacteriol. 1973 Aug;115(2):506–513. [PMC free article] [PubMed]
  • Pattus F, Massotte D, Wilmsen HU, Lakey J, Tsernoglou D, Tucker A, Parker MW. Colicins: prokaryotic killer-pores. Experientia. 1990 Feb 15;46(2):180–192. [PubMed]
  • Stroud R. Ion channel forming colicins. Curr Opin Struct Biol. 1995 Aug;5(4):514–520. [PubMed]
  • Cramer WA, Heymann JB, Schendel SL, Deriy BN, Cohen FS, Elkins PA, Stauffacher CV. Structure-function of the channel-forming colicins. Annu Rev Biophys Biomol Struct. 1995;24:611–641. [PubMed]
  • Gouaux E. The long and short of colicin action: the molecular basis for the biological activity of channel-forming colicins. Structure. 1997 Mar 15;5(3):313–317. [PubMed]
  • Boon T. Inactivation of ribosomes in vitro by colicin E 3 . Proc Natl Acad Sci U S A. 1971 Oct;68(10):2421–2425. [PMC free article] [PubMed]
  • Senior BW, Holland IB. Effect of colicin E3 upon the 30S ribosomal subunit of Escherichia coli. Proc Natl Acad Sci U S A. 1971 May;68(5):959–963. [PMC free article] [PubMed]
  • Schaller K, Nomura M. Colicin E2 is DNA endonuclease. Proc Natl Acad Sci U S A. 1976 Nov;73(11):3989–3993. [PMC free article] [PubMed]
  • Jakes KS, Zinder ND. Highly purified colicin E3 contains immunity protein. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3380–3384. [PMC free article] [PubMed]
  • Watson R, Rowsome W, Tsao J, Visentin LP. Identification and characterization of Col plasmids from classical colicin E-producing strains. J Bacteriol. 1981 Aug;147(2):569–577. [PMC free article] [PubMed]
  • Cooper PC, James R. Two new E colicins, E8 and E9, produced by a strain of Escherichia coli. J Gen Microbiol. 1984 Jan;130(1):209–215. [PubMed]
  • Sidikaro J, Nomura M. E3 immunity substance. A protein from e3-colicinogenic cells that accounts for their immunity to colicin E3. J Biol Chem. 1974 Jan 25;249(2):445–453. [PubMed]
  • Wallis R, Reilly A, Rowe A, Moore GR, James R, Kleanthous C. In vivo and in vitro characterization of overproduced colicin E9 immunity protein. Eur J Biochem. 1992 Jul 15;207(2):687–695. [PubMed]
  • Wallis R, Moore GR, James R, Kleanthous C. Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 1. Diffusion-controlled association and femtomolar binding for the cognate complex. Biochemistry. 1995 Oct 24;34(42):13743–13750. [PubMed]
  • Pugsley AP, Schwartz M. A genetic approach to the study of mitomycin-induced lysis of Escherichia coli K-12 strains which produce colicin E2. Mol Gen Genet. 1983;190(3):366–372. [PubMed]
  • Wallis R, Leung KY, Pommer AJ, Videler H, Moore GR, James R, Kleanthous C. Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 2. Cognate and noncognate interactions that span the millimolar to femtomolar affinity range. Biochemistry. 1995 Oct 24;34(42):13751–13759. [PubMed]
  • Wallis R, Reilly A, Barnes K, Abell C, Campbell DG, Moore GR, James R, Kleanthous C. Tandem overproduction and characterisation of the nuclease domain of colicin E9 and its cognate inhibitor protein Im9. Eur J Biochem. 1994 Mar 1;220(2):447–454. [PubMed]
  • Garinot-Schneider C, Pommer AJ, Moore GR, Kleanthous C, James R. Identification of putative active-site residues in the DNase domain of colicin E9 by random mutagenesis. J Mol Biol. 1996 Aug 2;260(5):731–742. [PubMed]
  • Curtis MD, James R. Investigation of the specificity of the interaction between colicin E9 and its immunity protein by site-directed mutagenesis. Mol Microbiol. 1991 Nov;5(11):2727–2733. [PubMed]
  • Osborne MJ, Lian LY, Wallis R, Reilly A, James R, Kleanthous C, Moore GR. Sequential assignments and identification of secondary structure elements of the colicin E9 immunity protein in solution by homonuclear and heteronuclear NMR. Biochemistry. 1994 Oct 18;33(41):12347–12355. [PubMed]
  • Osborne MJ, Breeze AL, Lian LY, Reilly A, James R, Kleanthous C, Moore GR. Three-dimensional solution structure and 13C nuclear magnetic resonance assignments of the colicin E9 immunity protein Im9. Biochemistry. 1996 Jul 23;35(29):9505–9512. [PubMed]
  • Osborne MJ, Wallis R, Leung KY, Williams G, Lian LY, James R, Kleanthous C, Moore GR. Identification of critical residues in the colicin E9 DNase binding region of the Im9 protein. Biochem J. 1997 May 1;323(Pt 3):823–831. [PMC free article] [PubMed]
  • Li W, Dennis CA, Moore GR, James R, Kleanthous C. Protein-protein interaction specificity of Im9 for the endonuclease toxin colicin E9 defined by homologue-scanning mutagenesis. J Biol Chem. 1997 Aug 29;272(35):22253–22258. [PubMed]
  • Chak KF, Safo MK, Ku WY, Hsieh SY, Yuan HS. The crystal structure of the immunity protein of colicin E7 suggests a possible colicin-interacting surface. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6437–6442. [PMC free article] [PubMed]
  • Hsieh SY, Ko TP, Tseng MY, Ku W, Chak KF, Yuan HS. A novel role of ImmE7 in the autoregulatory expression of the ColE7 operon and identification of possible RNase active sites in the crystal structure of dimeric ImmE7. EMBO J. 1997 Mar 17;16(6):1444–1454. [PMC free article] [PubMed]
  • Johnson ML, Correia JJ, Yphantis DA, Halvorson HR. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys J. 1981 Dec;36(3):575–588. [PMC free article] [PubMed]
  • Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. [PubMed]
  • Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240–255. [PubMed]
  • Ku WY, Wang CS, Chen CY, Chak KF, Safo MK, Yuan HS. Crystallization and preliminary X-ray crystallographic analysis of ImmE7 protein of colicin E7. Proteins. 1995 Dec;23(4):588–590. [PubMed]
  • Crosio MP, Janin J, Jullien M. Crystal packing in six crystal forms of pancreatic ribonuclease. J Mol Biol. 1992 Nov 5;228(1):243–251. [PubMed]
  • Janin J, Rodier F. Protein-protein interaction at crystal contacts. Proteins. 1995 Dec;23(4):580–587. [PubMed]
  • Brünger AT, Campbell RL, Clore GM, Gronenborn AM, Karplus M, Petsko GA, Teeter MM. Solution of a protein crystal structure with a model obtained from NMR interproton distance restraints. Science. 1987 Feb 27;235(4792):1049–1053. [PubMed]
  • Braun W, Epp O, Wüthrich K, Huber R. Solution of the phase problem in the X-ray diffraction method for proteins with the nuclear magnetic resonance solution structure as initial model. Patterson search and refinement for the alpha-amylase inhibitor tendamistat. J Mol Biol. 1989 Apr 20;206(4):669–676. [PubMed]
  • Baldwin ET, Weber IT, St Charles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BF, Clore GM, Gronenborn AM, et al. Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):502–506. [PMC free article] [PubMed]
  • Müller T, Oehlenschläger F, Buehner M. Human interleukin-4 and variant R88Q: phasing X-ray diffraction data by molecular replacement using X-ray and nuclear magnetic resonance models. J Mol Biol. 1995 Mar 24;247(2):360–372. [PubMed]
  • Weiss MS, Anderson DH, Raffioni S, Bradshaw RA, Ortenzi C, Luporini P, Eisenberg D. A cooperative model for receptor recognition and cell adhesion: evidence from the molecular packing in the 1.6-A crystal structure of the pheromone Er-1 from the ciliated protozoan Euplotes raikovi. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10172–10176. [PMC free article] [PubMed]
  • Wilmanns M, Nilges M. Molecular replacement with NMR models using distance-derived pseudo B factors. Acta Crystallogr D Biol Crystallogr. 1996 Sep 1;52(Pt 5):973–982. [PubMed]
  • Thunnissen MM, Taddei N, Liguri G, Ramponi G, Nordlund P. Crystal structure of common type acylphosphatase from bovine testis. Structure. 1997 Jan 15;5(1):69–79. [PubMed]
  • Wallis R, Moore GR, Kleanthous C, James R. Molecular analysis of the protein-protein interaction between the E9 immunity protein and colicin E9. Eur J Biochem. 1992 Dec 15;210(3):923–930. [PubMed]
  • Wallis R, Leung KY, Osborne MJ, James R, Moore GR, Kleanthous C. Specificity in protein-protein recognition: conserved Im9 residues are the major determinants of stability in the colicin E9 DNase-Im9 complex. Biochemistry. 1998 Jan 13;37(2):476–485. [PubMed]
  • Schreiber G, Fersht AR. Interaction of barnase with its polypeptide inhibitor barstar studied by protein engineering. Biochemistry. 1993 May 18;32(19):5145–5150. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • Protein
    Published protein sequences
  • PubMed
    PubMed citations for these articles
  • Structure
    Published 3D structures
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...